Roniel Cabrera is a Gastroenterology physician affiliated with University of Florida. OpenAlex indexes 118 publications with 3,859 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-392-9957Registry record last updated 14 Mar 2008.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20251 payment
- Ipsen Biopharmaceuticals, IncProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
46.4%Beta blocker22.1%Carvedilol100%Part D≥32 patientsAldosterone antagonist (MRA)15.5%Spironolactone100%Part D≥23 patients+ 1 more class in this area
Metabolism & gastrointestinal
37.4%Osmotic Laxative16.9%Lactulose100%Part D≥20 patientsRifamycin Antibacterial16.7%Xifaxan100%Part D<11 patients+ 1 more class in this area
Anti-infectives
7.4%Nucleoside and nucleotide reverse transcriptase inhibitors7.4%Tenofovir Disoproxil Fumarate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
Journal of Hepatocellular Carcinoma
2023 - A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis
Gastroenterology Research
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”